SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026071
Filing Date
2021-05-10
Accepted
2021-05-10 16:21:13
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q algs-10q_20210331.htm 10-Q 2388259
2 EX-10.1 algs-ex101_184.htm EX-10.1 89764
3 EX-10.2 algs-ex102_183.htm EX-10.2 92458
4 EX-10.3 algs-ex103_277.htm EX-10.3 100911
5 EX-10.4 algs-ex104_182.htm EX-10.4 84735
6 EX-31.1 algs-ex311_9.htm EX-31.1 18043
7 EX-31.2 algs-ex312_8.htm EX-31.2 18055
8 EX-32.1 algs-ex321_6.htm EX-32.1 8513
9 EX-32.2 algs-ex322_7.htm EX-32.2 8521
10 GRAPHIC gxumknts1mdz000002.jpg GRAPHIC 7127
11 GRAPHIC gxumknts1mdz000001.jpg GRAPHIC 3127
12 GRAPHIC gxumknts1mdz000003.jpg GRAPHIC 8262
  Complete submission text file 0001564590-21-026071.txt   7875972

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT algs-20210331.xml EX-101.INS 1396483
14 XBRL TAXONOMY EXTENSION SCHEMA algs-20210331.xsd EX-101.SCH 54755
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE algs-20210331_cal.xml EX-101.CAL 50460
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE algs-20210331_def.xml EX-101.DEF 192082
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE algs-20210331_lab.xml EX-101.LAB 458448
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE algs-20210331_pre.xml EX-101.PRE 341285
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39617 | Film No.: 21907529
SIC: 2836 Biological Products, (No Diagnostic Substances)